- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Sun Pharmaceutical Industries Ltd
Add to PortfolioSUNP:IN
569.55 INR 0.60 0.11%As of 07:06:33 ET on 05/25/2012.
Snapshot for Sun Pharmaceutical Industries Ltd (SUNP)
| Open: | 575.05 | Day's Range: | 567.75 - 580.00 | Volume: | 613,484 | Bid: | 569.55 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 568.95 | 52wk Range: | 448.00 - 610.75 | 1-Yr Rtn: | +28.89% | Ask: | 571.05 |
Key Statistics for SUNP
| Current P/E Ratio (ttm) | 32.4778 |
|---|---|
| Estimated P/E (03/2012) | 25.2796 |
| Earnings Per Share (INR) (ttm) | 17.5366 |
| Est. EPS (INR) (03/2012) | 22.5300 |
| Est. PEG Ratio | 2.2689 |
| Market Cap (M INR) | 586,582.94 |
| Shares Outstanding (M) | 1,029.91 |
| Enterprise Value (M INR) (ttm) | 576,680.85 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 6.2195 |
| Price/Sale (ttm) | 10.3089 |
| Dividend Indicated Gross Yield | 0.6145 |
| Next Earnings Announcement | 05/29/2012 |
More SUNP Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for SUNP
No data available.
Company Profile & Key Executives for SUNP
Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology.
| Dilip Shantilal ShanghviChairman/Managing Director | Subramanian KalyanasundaramCEO/Executive Director |
| Sudhir Vrundavandas ValiaExecutive Director | Sailesh T DesaiExecutive Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page